• Profile
Close

Long-term experience and outcomes of programmatic antiretroviral therapy for HIV-2 infection in Senegal, West Africa

Clinical Infectious Diseases Apr 03, 2020

Raugi DN, Ba S, Cisse O, et al. - Researchers sought to gather data on programmatic treatment outcome for people living with HIV-2 in West Africa, where the virus is most prevalent. For participation in this prospective, longitudinal observational cohort study, they invited HIV-2-infected adults who had initiated or were receiving ART through the Senegalese national AIDS program. At two sites, 291 participants were enrolled for 926.0 person-years of follow-up over 13 years. Among these patients, 21 deaths were reported (7.2%), and 117 individuals (40.2%) were lost to follow-up, including 43 (14.7%) who had an initial visit but never returned for follow-up. Participants in the Senegalese national AIDS program had earlier ART initiation in the course of disease, and improved outcomes were reported in correlation to receiving more modern therapeutic regimens. Despite these achievements, there remained sub-optimal HIV-2 treatment, and significant challenges to improving care.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay